CUSTOPHARM INC.
CARLSBAD, TX

VP of Business Development and Licensing William (Bill) has more than 23 years of experience in the pharmaceutical industry. Prior to joining Custopharm, Bill was vice president and general manager of Bedford Laboratories, Inc., where he oversaw a portfolio of more than 100 registered generic injectable products. Previously, he was senior director of product development at Amylin Pharmaceuticals Inc., where he managed development activities for proprietary peptide and protein injectable products. Bill also held positions at Novartis, ESI-Lederle, Barr Laboratories, Inc. and Schein Pharmaceutical, Inc. He began his career as an analytical research chemist. Bill received a doctorate degree in analytical chemistry from The Ohio State University and a bachelor’s degree in chemistry from Purdue University. Mohammad has more than (25) years of experience in the pharmaceutical industry. Prior to joining Custopharm, Mohammad has successfully managed manufacturing, engineering and technology transfer functions in regulated cGMP environments most recently with West Ward Pharmaceuticals. He has extensive knowledge and experience in process development and manufacturing of small and large molecule parenteral products, including biologics, nanoparticle suspensions, emulsions, liposome, liquid and lyophilized dosage forms packaged in vials, syringe, cartridges and bags. Mohammad in past has held positions with increasing responsibilities at Ben Venue Labs, Baxter Biopharma Solutions, American Pharmaceutical Partners and DOW Chemical Co. Mohammad received his Master’s degree in Industrial Engineering from University of Cincinnati and Bachelor’s degree in Mechanical Engineering from NED University of Engineering. Michael Davidson, VP of Business Development and Licensing Michael has more than 23 years of progressively increasing level of responsibilities working in the areas of Operations, Project Management, Strategic Sourcing, and Business Development & Licensing, while serving both the Branded and Generic sectors of the Pharmaceutical Industry. He is passionate about canvassing and exploring the global pharmaceutical landscape to identify and develop new strategic partnerships to bring affordable medicines into Custopharm’s portfolio to help serve and address the unmet needs of a growing and aging patient population. Mike has successfully designed, built and led numerous cross-functional and global teams to the highest level of performance within several top 20 Global Pharmaceutical Companies Worldwide during the course of his work tenure. Among his most recent previous positions, Mike served as Senior Director, Alliance Management for Pfizer, Inc. and Director of Business Development and Licensing for Bedford Laboratories. Elaine is responsible for the development and maintenance of internal quality systems as well as oversight of external partner quality and compliance activities. Elaine brings over 20 years of Quality Assurance and Regulatory experience within the pharmaceutical, biotechnology and medical device industries with 16 of those years leading quality activities in contract manufacturing and testing organizations, most recently with Ajinomoto Althea and Cardinal Health. Prior to joining Custopharm, Elaine lead preparation and inspection activities for regulatory site approval inspections, gaining 9 product approvals across 11 different countries. Elaine has also played an integral role in successfully developing quality systems and procedures in a phase appropriate manner at various companies from clinical start up to mature commercial manufacturing organizations. She is strongly focused on building partnerships and teams that focus on the patient-oriented goal of providing quality and safe products to those in need. Elaine holds a bachelor’s degree in Biology from De La Salle University. She also maintains active memberships with the Parenteral Drug Association (PDA), Regulatory Affairs Professionals Society (RAPS) and is quality certified by American Society for Quality (ASQ). We are currently recruiting for a number of career opportunities, including: analytical and formulation scientists, project managers, regulatory associates, financial analysts, and laboratory and office assistants. If you are interested in becoming part of an entrepreneurial, growing organization, please Custopharm is actively pursuing new product and partnership opportunities. We are looking to acquire sterile injectable products, strategically partner with development and manufacturing companies, and provide enhanced support If you are interested in opportunities to partner with Custopharm, Custopharm, Inc VP of Business Development and Licensing William (Bill) has more than 23 years of experience in the pharmaceutical industry. Prior to joining Custopharm, Bill was vice president and general manager of Bedford Laboratories, Inc., where he oversaw a portfolio of more than 100 registered generic injectable products. Previously, he was senior director of product development at Amylin Pharmaceuticals Inc., where he managed development activities for proprietary peptide and protein injectable products. Bill also held positions at Novartis, ESI-Lederle, Barr Laboratories, Inc. and Schein Pharmaceutical, Inc. He began his career as an analytical research chemist. Bill received a doctorate degree in analytical chemistry from The Ohio State University and a bachelor’s degree in chemistry from Purdue University. Mohammad has more than (25) years of experience in the pharmaceutical industry. Prior to joining Custopharm, Mohammad has successfully managed manufacturing, engineering and technology transfer functions in regulated cGMP environments most recently with West Ward Pharmaceuticals. He has extensive knowledge and experience in process development and manufacturing of small and large molecule parenteral products, including biologics, nanoparticle suspensions, emulsions, liposome, liquid and lyophilized dosage forms packaged in vials, syringe, cartridges and bags. Mohammad in past has held positions with increasing responsibilities at Ben Venue Labs, Baxter Biopharma Solutions, American Pharmaceutical Partners and DOW Chemical Co. Mohammad received his Master’s degree in Industrial Engineering from University of Cincinnati and Bachelor’s degree in Mechanical Engineering from NED University of Engineering.